Atlas Trials

Identify Effective Doses of SHR7280 Tablets in Controlled Ovarian Hyperstimulation (COH) for Female Subjects Undergoing Assisted Reproductive Technology (ART)

Clinical trial NCT05082233 · COMPLETED

Trial details

NCT number
NCT05082233
Sponsor
Jiangsu HengRui Medicine Co., Ltd.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Female Subjects Undergoing COH in ART to Prevent Early Ovulation
Start date
2022-03-06
Primary completion
2023-08-03
Enrollment
85

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.